Articles On Telix Pharmaceuticals (ASX:TLX)

“Your Stock Request” is a weekly video where we analyse share price charts for stocks on the Australian market (ASX) as requested by you! Email us at [email protected] with your stock request. Limit of one per person, no guarantee o...

ASX healthcare sector shows signs of recovery after latest earnings season Pathology and aged care face ongoing staffing and cost challenges Jarden highlights Telix Pharma and CSL as key investment picks   Key themes of FY24 reporting sea...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin World Overnight SPI Overnight 8196.00 – 9.00 – 0.11% S&P ASX 200 8152.90 –...

The Australian sharemarket experienced a decline from record highs, primarily due to investor concerns regarding the Reserve Bank's potential delay in interest rate cuts, expected to remain steady at 4.35 per cent for the seventh consecutiv...

Melbourne-based biotech Telix Pharmaceuticals (ASX: TLX) has expanded its North American manufacturing base through the acquisition of RLS (USA) Inc for up to US$250 million ($366.5 million). The deal gives Telix access to 31 licensed radi...

Telix Pharmaceuticals Limited (ASX: TLX), a prominent oncology company specializing in radiopharmaceuticals, has announced its acquisition of RLS (USA), Inc. for $338 million (USD 230 million). This strategic move significantly expands Teli...

Telix Pharmaceuticals Ltd (ASX: TLX) shares are falling on Monday morning. At the time of writing, the ASX 200 healthcare stock is down 3.5% to $19.57 Why is this ASX 200 healthcare stock falling? Investors have been selling the company's s...

The ASX 200 is forecasted to experience a downturn, with futures down 0.8% to 8190 points, following last week's record highs. A range of important economic events and corporate updates are expected to influence market movements.   The Aus...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia, INDIANAPOLIS and LAKE MARY, Fla., Sept. 23, 2024 /PRNewswi...

Melbourne-based Telix Pharmaceuticals Ltd (ASX:TLX) is set to expand its manufacturing and distribution footprint in North America with the acquisition of RLS Inc – the only US radiopharmacy network which is Joint Commission-accredited....

The S&P/ASX 200 Index (ASX: XJO) ended the trading week on a high this Friday. Literally so, with the index once again resetting its intraday trading re...

Aus shares have reached a record high, while Myer highlights challenging market conditions. Regis Healthcare and Kelsian have secured significant contracts, and Namoi Cotton has endorsed Olam Agri's acquisition bid. The Australian dollar ha...

It was a bouncy but overall positive day for the S&P/ASX 200 Index (ASX: XJO) this Thursday. By the time trading closed, the ASX 200 had climbed by ano...

It ended up being quite a wonderful day for the S&P/ASX 200 Index (ASX: XJO) this Tuesday. The ASX 200 managed to add 0.24% to its value and closed up at 8...

At 11:40am, the S&P/ASX 200 is 0.23 per cent higher at 8,140.50. This comes amid expectations of a significant 50 basis point interest rate cut by the Federal Reserve later this week, with JPMorgan predicting the move and CME Futures da...

The Australian sharemarket briefly touched a new record high on Monday, mirroring a surge in US stocks. Banks and gold stocks led the gains, while energy and health sectors lagged.At the closing bell, the S&P/ASX 200 was 0.27 per cent h...

At 11:35am, the S&P/ASX 200 is 0.37 per cent higher at 8,130.20, buoyed by a rally on Wall Street driven by gains in tech and gold stocks. US stocks surged on Friday amid expectations that the US Federal Reserve will lower interest rate...

Alive and Kicking is renowned biotech journo Tim Boreham’s new daily wrap covering morning movers and shakers of note in the ASX Healthcare sector, Monday through Thursday.   Prescient Therapeutics chief Steve Yatomi-Clarke resigns to hea...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia, Sept. 11, 2024 /PRNewswire/ — Telix Pharmaceuticals Limited...

Investors are keeping a close eye on several S&P/ASX 200 Index (ASX: XJO) shares, with two particular stocks standing out for their potential to outperform. These two companies represent different sectors—one in mining and the other in...

Below, we look at two compelling S&P/ASX 200 Index (ASX: XJO) shares you may wish to consider adding to your portfolio. One stock has been under intense selling pressure in 2024 while the other has seen its share price rocket. And David...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Welcome to the FNArena Corporate Results Monitor. Today’s Reports: ((AIS)) – Aeris...

Australian shares opened higher, buoyed by a rise in tech stocks, particularly Tesla and Amazon, which lifted the Nasdaq amid mixed performance on Wall Street. At 11:35am, the S&P/ASX 200 is 0.17 per cent higher at 7,995.60, with four o...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia, Sept. 4, 2024 /PRNewswire/ — Telix Pharmaceuticals Limited...

Noxopharm says two novel drug candidates significantly reduced glioblastoma (brain cancer) cell growth in preclinical models. Percheron Therapeutics announces “very encouraging” new data for its epilepsy program Cyclopharm is off to a soli...

In the first session of the week, the Australian sharemarket is experiencing a decline, primarily driven by weakness in mining and communications stocks. By midday, the S&P/ASX 200 index is down 0.3 per cent, hovering near 8067 points....

Telix Pharmaceuticals (ASX:TLX) CEO and co-founder Dr Chris Behrenbruch is blunt about why some fund managers believe the ASX market darling is entering ‘overvalued’ territory. “The fundies probably hate [us] because they didn’t get their a...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Looks like the local market is set for yet again a weaker opening on Thursday. Wor...

The Australian share market closed flat on Wednesday, with consumer staples offsetting losses in commodity stocks. Woolworths' strong earnings boosted the consumer staples sector, while lower iron ore and uranium prices weighed on mining an...

Telix Pharmaceuticals (ASX:TLX) has announced its receipt of fast track status from the US FDA within the approvals chain for the assessment of Telix’s PET-scan brain cancer imaging agent Pixclara. The company is focusing particularly on...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia, Aug. 28, 2024 /PRNewswire/ – Telix Pharmaceuticals Limited...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin World Overnight SPI Overnight 7996.00 – 29.00 – 0.36% S&P ASX 200 8071.20...

Telix Pharmaceuticals Ltd (ASX: TLX) shares are drifting higher on Tuesday, extending gains to 98% for the year to date. Shares in the biopharmaceutical company are swapping hands less than 1% higher at $19.90 apiece at the time of publ...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia, Aug. 27, 2024 /PRNewswire/ — Telix Pharmaceuticals Limited...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin World Overnight SPI Overnight 8041.00 + 4.00 0.05% S&P ASX 200 8084.50 + 6...

ASX ended 10-day winning streak ANZ, Tabcorp dropped after facing regulators Despite a crude price rebound, energy stocks fell   The ASX 200 ended its 10-day winning streak, dipping by 0.04% after a weak session on Wall Street overnight....

For chief executives and institutional investors, the critical phase of earnings season begins after the analyst calls, media interviews, and the presentation of results have concluded. Investor roadshows offer a unique opportunity for fund...

Australian shares are poised to end a 10-day winning streak on Friday, with the market opening down 0.2 percent at 8008 points. This decline follows a negative session on Wall Street, where the Nasdaq (NASDAQ:IXIC) experienced a drop of 1.7...

The Telix Pharmaceuticals Ltd (ASX: TLX) share price is on the move on Friday morning. At the time of writing, the ASX 200 healthcare stock is down 9% to $18.04. This follows the release of its half-year results after the market close yeste...

On Thursday, the S&P/ASX 200 Index (ASX: XJO) recorded a modest gain, rising 0.2% to close at 8,027 points. As the market gears up for Friday’s session, several factors could influence the day's performance: ASX 200 Set for a Slight Di...

On Thursday, the S&P/ASX 200 Index (ASX: XJO) had another decent session and recorded a small gain. The benchmark index rose 0.2% to 8,027 points. Will the market be able to build on this on Friday and end the week on a high? Here are...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia, Aug. 22, 2024 /PRNewswire/ — Telix Pharmaceuticals Limited...

At 11:40am, the S&P/ASX 200 is 0.07 per cent lower at 7,965.9, the Australian share market opened lower, influenced by a decline in consumer staples stocks. Investors reacted to a wave of company earnings released on Monday. A2 Milk exp...

At 11:30am, the S&P/ASX 200 is 1.39 per cent higher at 7,974.5, driven by optimism about potential interest rate cuts and robust economic data. Investors responded positively to strong US retail sales and positive GDP figures from Japan...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Rudi Filapek-Vandyck By Rudi Filapek-Vandyck, Editor Morningstar's Best Equity Ideas for A...

It's been a bouncy, yet positive session for the S&P/ASX 200 Index (ASX: XJO) and most ASX 200 shares so far this Tuesday. At the time of writing, the ASX 200 has added a decent 0.17%, putting the index at around 7,830 points. But it wo...

The S&P/ASX 200 Index (ASX: XJO) comprises 11 market sectors, and the outperformer over the past decade may surprise you. It's not the flashy tech sector, nor the sectors home to the mega-miners or the Big Four bank shares. I...

At 11:40am, the S&P/ASX 200 is 0.2 per cent higher at 7,695.60. Michele Bullock's calm and steady demeanor as a central banker is essential to mitigating market panic. She effectively reassured the market with the RBA's statement and he...

The Australian sharemarket rebounded today after heavy selling yesterday. At noon, the S&P/ASX 200 is 0.2 per cent higher at 7,665. This rebound comes amid a broader global market upheaval triggered by growing concerns over a potential...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin World Overnight SPI Overnight 8084.00 + 23.00 0.29% S&P ASX 200 8092.30 +...